Intercontinental Exchange, Inc.

IC2.DE·XETRA·Financial Services
Compare
157.65+2.95 (+1.91%)today
As of Nov 5, 1:17 PM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close154.70
Open155.70
Day range155.70157.65
52-week range108.25157.65
Off day high0.00%
Off 52-week high0.00%
Volume31.00
Avg. volume (3M)48.00
Market cap88.10B
EPS (TTM)6.32
Forward P/E—
P/E ratio (TTM)24.94
Dividend yield1.21% (1.86)
Beta (5Y)0.84
Shares outstanding558.86M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin38.14%

Against its peers

Compare in full ›
IC2.DE SOU.F LSEG.L 0388.HK CME 0QVJ.IL
Market cap 88.10B 15.42B 47.30B 498.77B 110.34B 18.44B
P/E (TTM) 24.9 33.5 35.5 25.2 25.3 47.6
Forward P/E — — 18.0 24.7 23.3 —
Price/book 3.3 9.3 2.6 8.2 4.1 4.8
Dividend yield 1.21% 2.36% 1.61% 3.87% 1.69% 3.35%
1-year change +21.75% +27.14% +3.29% −9.35% +13.58% +40.34%
Today +1.91% +2.13% +0.90% +2.76% +1.38% +1.58%

The closest companies by business and industry (Financial Data & Stock Exchanges). Prices may be delayed up to 15 min.

Latest news

All IC2.DE news ›
Stock Titan·Positive

Intercontinental Exchange Q3 net revenue rises 15%

SEGG Media Reports More Than 1,500% Year-Over-Year Revenue Growth in Second Quarter, Driven by Veloce uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the…

ICE
Stock Titan·Positive

Intercontinental Exchange Q3 profit rises to $940M

uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease Palantir Reports Q3 2026 U.S. Comm Revenue Growth of 148% Y/Y and Revenue…

From the 4Search news index, newest first.

In the news

76mentions in 30 days
76with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 76 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance